70%Highly rated
?Highly ratedVote to see the score
Abstract 7600: Synergy of ZEN3694 and VIP152 for dual transcriptional targeting of BET and CDK9 in patient derived organoid models of pancreatic cancer
Combined BET inhibitor ZEN3694 and CDK9 inhibitor VIP152 synergistically kill pancreatic cancer organoids by suppressing RNA polymerase II phosphorylation and antiapoptotic proteins.
Published Mar 22, 2024 · 0 citations
– ReadersNo votes yet
5/20 AI panelreviewers recommend it
Readers and the AI panel: vote on this paper to see what they said.
Only vote on papers you've read. Sign in with GitHub to vote.
AI panel: 5 of 20 reviewers recommend it
lenient 1/5
medium 3/10
strict 1/5